Inactive Instrument

Accentia Biopharmaceuticals Inc Share Price

Stocks

11/09/12	Accentia Biopharmaceuticals Inc : Biovest Names Lymphoma Key Opinion Leader from MD Anderson Cancer Center to Scientific Advisory Board	PU
13/07/12	Accentia Biopharmaceuticals Inc : Biovest’s Eligibility to Seek EU Marketing Approval for its BiovaxID Cancer Vaccine as Orphan Drug Confirmed by EMA	PU
30/05/12	Accentia Biopharmaceuticals Inc : Biovest Names Dr. Eduardo Sotomayor, Chair of Dept of Malignant Hematology at Moffitt Cancer Center, to its Scientific Advisory Board	PU
18/05/12	Accentia Biopharmaceuticals Inc : Biovest Announces BiovaxID® ASCO Abstract Available On-line; NCI to Present Cancer Vaccine Data from Mantle Cell Lymphoma Study	PU
16/05/12	Accentia Biopharmaceuticals Inc : Biovest Retains Ferghana Partners to Evaluate Strategic Transactions	PU

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ACCENTIA BIOPHARMACEUTICALS INC	-.--%	-.--%	-	-	0
LONZA GROUP AG	+1.70%	+7.41%	+3.12%	+8.46%	49.92B
REVOLUTION MEDICINES, INC.	+0.92%	+3.93%	+399.71%	+605.33%	40.23B
IQVIA HOLDINGS INC.	+1.89%	+8.32%	+26.06%	-6.35%	34.55B
BEONE MEDICINES AG	+2.38%	+6.35%	+21.25%	+64.58%	33.09B
CELLTRION, INC.	+3.96%	+10.67%	+11.89%	+38.86%	27.51B
ASCENDIS PHARMA A/S	+2.51%	+5.27%	-	-	17.05B
MEDPACE HOLDINGS, INC.	+2.58%	+5.79%	+73.44%	+133.27%	15.92B
EUROFINS SCIENTIFIC SE	+0.32%	+0.58%	+13.67%	+19.09%	13.86B
IONIS PHARMACEUTICALS, INC.	+3.30%	+0.76%	+90.23%	+99.12%	13.52B
Average	+1.96%	+5.82%	+79.92%	+120.30%	27.3B
Weighted average by Cap.	+2.07%	+6.53%	+90.75%	+137.74%

Employees

Sector